Acadia Healthcare Company, Inc. ACHC
28.09
0.29
1.04%
as of 25 Sep
- Market cap
- $2.6B
- P/E
- 0.0×
Follow ACHC
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
20.98 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.69 | 0.39 | 0.63 | 0.80 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
30.58 | (14.92) | 34.41 | 16.55 | |
P/B ratio |
0.72 | 0.66 | 1.08 | 1.36 | |
Price to Tangible BV |
2.99 | 2.32 | 3.79 | 4.66 | |
EV/Sales |
1.36 | 1.10 | 1.33 | 1.46 | |
EV/EBITDA |
7.02 | 6.28 | 7.56 | 9.12 | |
EV/Operating CF |
13.23 | 27.70 | 24.65 | 23.40 | |
EV/FCF |
(13.68) | (8.78) | (17.83) | (49.10) | |
Quick Ratio |
1.06 | 1.09 | 1.29 | 1.19 | |
Current Ratio |
1.44 | 1.55 | 1.71 | 1.57 | |
Net Debt/EBITDA |
13.02 | 24.98 | 17.22 | 16.09 | |
Debt/Assets |
36.01% | 45.23% | 45.56% | 43.53% | |
Debt/Equity |
0.74 | 1.28 | 1.29 | 1.22 | |
Asset Turnover |
0.53 | 0.58 | 0.58 | 0.57 | |
Operating CF/Net income |
2.02 | 0.07 | 14.99 | 14.83 | |
Capex/Depreciation |
(2.66) | (1.96) | (1.12) | (0.55) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
63.89% | 65.73% | 66.33% | 64.68% | |
Intangible Assets out of Total Assets |
0.37 | 0.25 | 0.25 | 0.25 | |
Share Based Compensation of Revenue |
0.71% | 0.79% | 0.96% | 1.27% | |
Graham Net Nets |
(1.14) | (2.15) | (1.30) | (1.01) | |
Graham Number |
30.27 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.77% | (85.98%) | (52.33%) | (42.16%) | |
Free Cash Flow Yield |
(14.47%) | (32.33%) | (11.88%) | (3.74%) | |
Revenue per Share |
9.42 | 9.06 | 9.16 | 9.53 | |
Operating CF per Share |
0.81 | (0.95) | 0.68 | 1.78 | |
Capex per Share |
(1.43) | (1.02) | (0.66) | (0.31) | |
Free Cash Flow per Share |
(0.62) | (1.97) | 0.01 | 1.47 | |
Cash per Share |
1.31 | 1.47 | 1.75 | 1.89 | |
Shareholders Equity per Share |
34.51 | 21.49 | 21.63 | 21.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
34.51 | 21.49 | 21.63 | 21.79 | |
Free Cash Flow |
(56.50) | (178.79) | 1.35 | 133.63 | |
Working Capital |
230.03 | 288.95 | 347.84 | 307.71 | |
Capital Expenditures |
(129.71) | (92.49) | (60.18) | (28.44) | |
Net Current Asset Value |
(2,544.49) | (2,764.35) | (2,750.98) | (2,721.92) | |
EV/EBIT |
9.98 | 9.42 | 11.41 | 14.54 | |
Capex to Sales |
0.15 | 0.11 | 0.07 | 0.03 | |
Net Profit Margin |
4.26% | (143.34%) | 0.50% | 1.26% | |
Price to Operating Income |
5.04 | 3.32 | 5.38 | 7.92 | |
| Other line items | |||||
Average Receivables |
407.39 | 402.97 | 434.19 | 439.65 | |
Average Payables |
190.66 | 191.55 | 173.11 | 177.54 | |
Average Assets |
6,141.60 | 5,742.18 | 5,847.02 | 5,927.34 | |
Average Common Equity |
3,075.91 | 2,511.34 | 2,499.92 | 2,528.55 |
Columns are period end dates